Loading Events

All Events

Delivering on the Promise of Genetic Medicine with Next-Generation CRISPR Cures

Mammoth Biosciences is a biotechnology company focused on leveraging its proprietary ultracompact CRISPR systems to develop long-term curative therapies, as well as other applications such as decentralized precision diagnostics. Founded by CRISPR pioneer and Nobel laureate Jennifer Doudna and Trevor Martin, Janice Chen, and Lucas Harrington, the company’s ultracompact proteins are designed to enable in vivo gene editing in difficult to reach tissues utilizing both nuclease applications and new editing modalities beyond double stranded breaks, including base editing, gene writing, and epigenetic editing.

Our Speakers

Trevor Martin, Ph.D.
Co-Founder and CEO

Trevor Martin is the co-founder and CEO of Mammoth Biosciences, a biotechnology company based in the San Francisco Bay Area. Trevor earned his BA from Princeton University and his Ph.D. in Biology from Stanford. His scientific work has been featured in outlets including FiveThirtyEight and The Atlantic. He is the featured healthcare honoree on the Forbes 30 Under 30 list, is on Fortune’s 40 Under 40 list, and is an EY Entrepreneur of the Year 2021.

Register:

RSVP July 25, 2024
First
Last
How did you hear about this event?

Feel free to share!

Go to Top